BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oshi MA, Lee J, Naeem M, Hasan N, Kim J, Kim HJ, Lee EH, Jung Y, Yoo J. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core–Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis. Biomacromolecules 2020;21:3571-81. [DOI: 10.1021/acs.biomac.0c00589] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun L, Ouyang J, Zeng F, Wu S. An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome. Biomaterials 2022;283:121468. [DOI: 10.1016/j.biomaterials.2022.121468] [Reference Citation Analysis]
2 Tan Y, Liu Y, Liu Y, Ma R, Luo J, Hong H, Chen X, Wang S, Liu C, Zhang Y, Chen T. Rational Design of Thermosensitive Hydrogel to Deliver Nanocrystals with Intranasal Administration for Brain Targeting in Parkinson's Disease. Research (Wash D C) 2021;2021:9812523. [PMID: 34888525 DOI: 10.34133/2021/9812523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lechner K, Zeeshana M, Noack M, Ali H, Neurath M, Weigmanna B. Small but powerful: Will nanoparticles be the future state‐of‐the‐art therapy for IBD? Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2043847] [Reference Citation Analysis]
4 Liu P, Li Y, Wang R, Ren F, Wang X. Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease. Biomedicines 2022;10:85. [DOI: 10.3390/biomedicines10010085] [Reference Citation Analysis]
5 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Reference Citation Analysis]
6 Pathomthongtaweechai N, Muanprasat C. Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption. Pharmaceutics 2021;13:887. [PMID: 34203816 DOI: 10.3390/pharmaceutics13060887] [Reference Citation Analysis]
7 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Reference Citation Analysis]
8 Bai M, Yang M, Gong J, Xu H, Wei Z. Progress and Principle of Drug Nanocrystals for Tumor Targeted Delivery. AAPS PharmSciTech 2021;23:41. [PMID: 34964079 DOI: 10.1208/s12249-021-02200-w] [Reference Citation Analysis]
9 Vikulina AS, Campbell J. Biopolymer-Based Multilayer Capsules and Beads Made via Templating: Advantages, Hurdles and Perspectives. Nanomaterials (Basel) 2021;11:2502. [PMID: 34684943 DOI: 10.3390/nano11102502] [Reference Citation Analysis]
10 Oshi MA, Lee J, Kim J, Hasan N, Im E, Jung Y, Yoo JW. pH-Responsive Alginate-Based Microparticles for Colon-Targeted Delivery of Pure Cyclosporine A Crystals to Treat Ulcerative Colitis. Pharmaceutics 2021;13:1412. [PMID: 34575488 DOI: 10.3390/pharmaceutics13091412] [Reference Citation Analysis]
11 Wang Y, Li Y, He L, Mao B, Chen S, Martinez V, Guo X, Shen X, Liu B, Li C. Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment. Colloids Surf B Biointerfaces 2021;203:111756. [PMID: 33865087 DOI: 10.1016/j.colsurfb.2021.111756] [Reference Citation Analysis]
12 Wang L, Yu M, Yang H. Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease. J Inflamm Res 2021;14:1701-16. [PMID: 33953597 DOI: 10.2147/JIR.S304101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang X, Zhao X, Tie S, Li J, Su W, Tan M. A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation. J Control Release 2022:S0168-3659(22)00028-1. [PMID: 35038495 DOI: 10.1016/j.jconrel.2022.01.014] [Reference Citation Analysis]
14 Dos Santos AM, Carvalho SG, Meneguin AB, Sábio RM, Gremião MPD, Chorilli M. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release 2021;334:353-66. [PMID: 33901582 DOI: 10.1016/j.jconrel.2021.04.026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Li S, Zhang H, Chen K, Jin M, Vu SH, Jung S, He N, Zheng Z, Lee MS. Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges. Drug Deliv 2022;29:1142-9. [PMID: 35384787 DOI: 10.1080/10717544.2022.2058646] [Reference Citation Analysis]
16 Marin E, Tapeinos C, Sarasua J, Larrañaga A. Exploiting the layer-by-layer nanoarchitectonics for the fabrication of polymer capsules: A toolbox to provide multifunctional properties to target complex pathologies. Advances in Colloid and Interface Science 2022. [DOI: 10.1016/j.cis.2022.102680] [Reference Citation Analysis]
17 Yang L, Shuyuan S, Huang G, Yingchong C, Shen B, Yue P. Nanocrystals based mucosal delivery system: Research Advances. Drug Dev Ind Pharm 2022;:1-29. [PMID: 35287534 DOI: 10.1080/03639045.2022.2053985] [Reference Citation Analysis]
18 Mirdamadian SZ, Varshosaz J, Minaiyan M, Taheri A. 3D printed tablets containing oxaliplatin loaded alginate nanoparticles for colon cancer targeted delivery. An in vitro/in vivo study. Int J Biol Macromol 2022:S0141-8130(22)00322-1. [PMID: 35182561 DOI: 10.1016/j.ijbiomac.2022.02.080] [Reference Citation Analysis]